However, cases with low cellularity may yield false-negative results, requiring pathologist intervention to ensure evaluation exclusively of cancer cells, thereby avoiding the inclusion of non-cancer cells that distort HER2 and CEP17 copy number per cell averages. The gene discussed is ERBB2; the disease is cancer.